Last reviewed · How we verify

NCT06228417

A Mobile App for Medication Adherence in Persons With Hypertension: a Pilot Study

Completed Last updated 19 March 2024
What this trial tests

trial testing Adaptive digital intervention in Hypertension in 14 participants. Completed in 1 March 2021.

Timeline
23 February 2020
Primary endpoint
27 February 2021
1 March 2021

Quick facts

Lead sponsorHalmstad University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment14
Start date23 February 2020
Primary completion27 February 2021
Estimated completion1 March 2021
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Halmstad University

Who can join

Adults 40 to 70, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A development and pilot test of an app targeting persons with hypertension. Content in the app was based on persons with hypertensions experiences and a literature review. The participants experience of using the app as well as testing a instrument for medication adherence.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other Halmstad University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06228417.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing